OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · IEX Real-Time Price · USD
1.460
-0.030 (-2.01%)
Mar 28, 2024, 11:53 AM EDT - Market open

Total Valuation

OKYO Pharma has a market cap or net worth of $49.85 million. The enterprise value is $48.02 million.

Market Cap 49.85M
Enterprise Value 48.02M

Important Dates

The next estimated earnings date is Tuesday, April 9, 2024, before market open.

Earnings Date Apr 9, 2024
Ex-Dividend Date n/a

Share Statistics

OKYO Pharma has 33.24 million shares outstanding. The number of shares has increased by 29.71% in one year.

Shares Outstanding 33.24M
Shares Change (YoY) +29.71%
Shares Change (QoQ) +32.82%
Owned by Insiders (%) 25.72%
Owned by Institutions (%) 2.53%
Float 13.64M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.72

Current Ratio 0.72
Quick Ratio 0.64
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -136.39

Financial Efficiency

Return on equity (ROE) is -2,968.50% and return on invested capital (ROIC) is -8,146.58%.

Return on Equity (ROE) -2,968.50%
Return on Assets (ROA) -279.30%
Return on Capital (ROIC) -8,146.58%
Revenue Per Employee n/a
Profits Per Employee -$1.66M
Employee Count 8
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -12,202
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +14.50% in the last 52 weeks. The beta is -3.17, so OKYO Pharma's price volatility has been lower than the market average.

Beta (1Y) -3.17
52-Week Price Change +14.50%
50-Day Moving Average 1.49
200-Day Moving Average 1.63
Relative Strength Index (RSI) 50.19
Average Volume (30 Days) 192,644

Short Selling Information

The latest short interest is 50,789, so 0.15% of the outstanding shares have been sold short.

Short Interest 50,789
Short Previous Month 64,634
Short % of Shares Out 0.15%
Short % of Float 0.37%
Short Ratio (days to cover) 1.48

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -13.19M
Pretax Income -13.28M
Net Income -13.27M
EBITDA -13.18M
EBIT -13.19M
Earnings Per Share (EPS) -$0.61
Full Income Statement

Balance Sheet

The company has $4.05 million in cash and $2.22 million in debt, giving a net cash position of $1.83 million or $0.06 per share.

Cash & Cash Equivalents 4.05M
Total Debt 2.22M
Net Cash 1.83M
Net Cash Per Share $0.06
Equity / Book Value -2.05M
Book Value Per Share -0.06
Working Capital -2.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.70 million and capital expenditures -$5,916, giving a free cash flow of -$7.70 million.

Operating Cash Flow -7.70M
Capital Expenditures -5,916
Free Cash Flow -7.70M
FCF Per Share -$0.27
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.71%
Shareholder Yield -29.71%
Earnings Yield -26.62%
FCF Yield -15.45%

Analyst Forecast

The average price target for OKYO Pharma is $7.00, which is 379.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.00
Price Target Difference 379.45%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1